Goldman Sachs
HOOK

Goldman Sachs’s HOOKIPA Pharma HOOK Stock Holding History

Goldman Sachs’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,809
Closed -$24K – 6115
2022
Q3 		$24K Sell
1,809
-2,616
-59% -$40.2K ﹤0.01% 5905
2022
Q2 		$73K Sell
4,425
-4,297
-49% -$71.1K ﹤0.01% 5947
2022
Q1 		$199K Buy
8,722
+4,717
+118% +$84.5K ﹤0.01% 5889
2021
Q4 		$93K Buy
4,005
+2,609
+187% +$105K ﹤0.01% 6152
2021
Q3 		$82K Sell
1,396
-2,057
-60% -$149K ﹤0.01% 5945
2021
Q2 		$316K Sell
3,453
-13,945
-80% -$1.86M ﹤0.01% 5490
2021
Q1 		$2.34M Buy
17,398
+15,493
+813% +$1.87M ﹤0.01% 3836
2020
Q4 		$211K Buy
+1,905
New +$206K ﹤0.01% 5063
2019
Q3 		– Sell
-3,771
Closed -$254K – 5253
2019
Q2 		$254K Buy
+3,771
New +$400K ﹤0.01% 4683

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs's HOOK Position: Q4 2022 in Review

Goldman Sachs sold out of HOOKIPA Pharma (HOOK) in Q4 2022, closing a stake of 1,809 shares — an estimated $24K sold.

Goldman Sachs first reported a position in HOOK in Q2 2019 and held it in 9 quarters. The position peaked at $2.34M in Q1 2021. 55 funds tracked by Wall St. Rank hold HOOK as of Q4 2022.

  • Goldman Sachs reported no remaining HOOKIPA Pharma position as of Q4 2022 after selling out during the quarter.
  • Goldman Sachs sold 1,809 HOOKIPA Pharma shares in Q4 2022, an estimated $24K.
  • Goldman Sachs first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 9 quarters.
  • Goldman Sachs's HOOKIPA Pharma position peaked at $2.34M in Q1 2021.
  • 55 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.